Zafgen, Inc. (Nasdaq: ZFGN) announced that the Company has recently initiated dosing in the multiple ascending dose (MAD) cohorts of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE